HAMBURG, Germany – Like any other sector, biotechnology has to engage with the wider political and economic environment it inhabits, as well as deal with the issues that are specific to it. A BIO-Europe panel discussion on transformative deals in 2019 concluded with a slightly nervous look ahead to what is increasingly looking like an uncertain macroeconomic situation.